Disulfidptosis in osteoarthritis: Role of SLC2A3 downregulation and potential therapeutic implications

This study providing functional evidence for a potential association between disulfidptosis-related genes and OA, while highlighting SLC2A3 as a potential functional regulator for further investigation. Additionally, was identified talaroflavone as a computationally predicted lead compound that warrants future experimental validation. These findings not only enhance our understanding of the molecular pathways underlying OA but also lay the groundwork for potential development of targeted therapeutic strategies.